Schizophrenia and other Psychoses
VIZMARC V. SANTOS, RN, MSN
Faculty - Lecturer CIT-U I CNAHS - Nursing, Cebu Institute of Technology University
Definition: Disruptive mental state affecting the distinction between internal perceptions and the external world.
Psychotic Manifestations:
Sensory-Perceptual Alterations
Inability to relate to others
Thought process disturbances
SISAs include Schizophrenia, Intoxication, Severe Depression, Acute Mania.
Major psychotic syndrome causing distorted thoughts, perceptions, emotions, movements, and behaviors.
Chronic illness requiring long-term management and coping strategies.
1860: Morel termed psychiatric symptoms as "Dementia praecox."
1871: Kahlbaum used "catatonia" for immobilized patients.
1874: Hecker described "hebephrenia" for silly and regressed behaviors.
1878: Kraeplin introduced the term "paranoia" for highly suspicious patients.
1899: Kraeplin grouped these terms under "dementia praecox."
1908: Bleuler coined the term "schizophrenia."
Affective disturbance: Inappropriate or flat affect
Autism: Preoccupation with self
Associative looseness: Unrelated topics in discourse
Ambivalence: Simultaneous opposite feelings
Derived from Greek terms "skhizo" (split) and "phren" (mind).
Onset: Typically from late adolescence to early adulthood
Gender prevalence: Affects both men and women equally
National morbidity: 1 million Filipinos afflicted (DOH, 2018).
Premorbid
Prodromal
Schizophrenia
Residual
Patients often have schizoid or schizotypal personalities.
Characteristics: Social withdrawal, introversion.
Transition from premorbid functioning to psychotic symptoms (weeks to months).
Sleep disturbance
Anxiety
Irritability
Depressed mood
Poor concentration
Fatigue
Social withdrawal
Perceptual abnormalities
Ideas of reference
Suspiciousness
Characterized by prominent psychotic symptoms.
Diagnostic criteria according to DSM.
May follow the active phase.
Acute symptoms decrease in intensity.
Sibling with schizophrenia: 10% risk
One parent with schizophrenia: 5%-6% risk
Twin Studies: Identical twins have 4x the risk compared to fraternal twins.
Adoption Studies: Children of schizophrenic mothers at higher risk.
Excess dopamine activity linked to schizophrenia:
Increased production/release at nerve terminals
Increased receptor sensitivity
Too many dopamine receptors
Similar observations as noted previously: Higher risk for children born to affected mothers.
Linked to dopamine dysregulation.
Dopamine locations:
Ventral tegmentum area
Substantia nigra
Positive symptoms: Result from elevated dopamine levels affecting the limbic area.
Negative symptoms: Related to hypodopaminergic processes in the mesocortical tract.
Ambivalence
Associative looseness
Delusions
Echopraxia
Flight of ideas
Hallucinations
Ideas of reference
Perseveration
Bizarre behavior
Alogia
Anhedonia
Apathy
Asociality
Blunted affect
Catatonia
Flat affect
Avolition
Inattention
Paranoid Schizophrenia: Hallucinations, persecutory delusions, religiosity, suspiciousness
Disorganized Schizophrenia: Loose associations, bizarre behavior, flat/inappropriate affect
Catatonic Schizophrenia: Stupor, waxy flexibility, mutism, echopraxia
Residual Schizophrenia: In remission but still shows flat affect and social withdrawal.
Mainstay treatment; controls but does not cure symptoms.
Third-Generation Antipsychotics: Stabilize dopamine system (e.g., Aripiprazole).
Second-Generation Antipsychotics: Affect both positive and negative symptoms (e.g., Clozapine, Olanzapine, Risperidone).
First-Generation Antipsychotics: Primarily target positive symptoms (e.g., Chlorpromazine, Haloperidol).
Uses sesame oil for slow absorption.
Depot injections (e.g., Fluphenazine, Risperidone, Olanzapine).
Transition to depot injections after stable oral regimen.
Areas affected include Cortex, Striatum, Thalamus, and more.
Pseudoparkinsonism
Akathisia
Dystonia
Tardive Dyskinesia
Agranulocytosis
Neuroleptic Malignant Syndrome (NMS)
Restlessness and fidgeting; common onset at 50-60 days.
Management includes Propranolol.
Symptoms: Tremors, rigidity; onset 1-5 days.
Management with antiparkinsonian medications (e.g., Amantadine).
Involuntary spasms; more common in men under 25.
Management includes anticholinergics and other supportive measures.
Late-appearing, often irreversible side effect.
Symptoms: Involuntary movements (e.g., tongue protrusion, lip smacking).
Hold medications at initial signs and monitor with AIMS scale.
Agranulocytosis: Low WBC levels, managed by monitoring and controlling dispensing of medication.
NMS: Rare, life-threatening condition requiring immediate action (discontinuation of antipsychotics).
Promote safety and privacy.
Establish trust and therapeutic relationships.
Use therapeutic communication techniques.
Avoid confrontation and argue.
Base interaction on reality.
Gradually present doubts regarding delusions.
Elicit descriptions of hallucinations.
Maintain reality with contact and communication.
Redirect inappropriate behaviors.
Address behaviors non-judgmentally.
Reassure others that behaviors are not the patient's fault.
Encourage reintegration into treatment milieu.
Teach relevant social skills.